Can Isomorphic Labs Turn AlphaFold Into an Engine for Drug Discovery?
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Alphabet offshoot Isomorphic Labs aims to use the Nobel Prize-winning protein-modelling tool AlphaFold to develop new medicines. Thrive Capital pursued the previously closed startup for 18 months, seeking a stake despite Isomorphic not actively raising funds.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu